Colossal Biosciences
Colossal Biosciences raises $120M Growth at $10.2B valuation
Quick Facts
Colossal Biosciences: Growth Funding Round
Colossal Biosciences has successfully raised $120M in Growth funding, reaching a valuation of $10.2B.
Company Overview
De-extinction company using genetic engineering to revive extinct species like mammoths
Funding Details
The Growth round was led by Peter Jackson, with participation from multiple investors.
Company Information
- Headquarters: Austin, TX
- Founded: 2021
- Employees: 150+
- Category: HealthTech
Investment
Colossal Biosciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Peter Jackson: Verified investor in Growth
- multiple investors: Verified investor in Growth
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
